These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 20928976)
1. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia]. Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976 [TBL] [Abstract][Full Text] [Related]
2. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis. Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042 [TBL] [Abstract][Full Text] [Related]
3. Abdominal obesity and expression of familial combined hyperlipidemia. van der Kallen CJ; Voors-Pette C; de Bruin TW Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407 [TBL] [Abstract][Full Text] [Related]
4. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees. Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552 [TBL] [Abstract][Full Text] [Related]
5. Genetic dissection of familial combined hyperlipidemia. Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807 [TBL] [Abstract][Full Text] [Related]
6. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES. Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446 [TBL] [Abstract][Full Text] [Related]
7. Unraveling the complex genetics of familial combined hyperlipidemia. Suviolahti E; Lilja HE; Pajukanta P Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803 [TBL] [Abstract][Full Text] [Related]
8. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118 [TBL] [Abstract][Full Text] [Related]
9. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056 [TBL] [Abstract][Full Text] [Related]
14. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained? Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518 [TBL] [Abstract][Full Text] [Related]
15. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia. Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748 [TBL] [Abstract][Full Text] [Related]
16. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia. Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806 [TBL] [Abstract][Full Text] [Related]
17. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families. Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia. de Graaf J; van der Vleuten G; Stalenhoef AF Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632 [TBL] [Abstract][Full Text] [Related]
19. [An association of apolipoprotein B with pulse pressure in Chinese pedigrees with familial combined hyperlipidemia]. Pei WD; Sun YH; Zhang J; Liu Q; Jing ZC; Qiu DY; Liu YH; Gong J; Feng TJ; Lu ZL; Hui RT; Wu XG; Liu LS Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):380-3. PubMed ID: 15061989 [TBL] [Abstract][Full Text] [Related]
20. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination. Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]